These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 29479037)

  • 1. Role of cytochrome P450-mediated metabolism and involvement of reactive metabolite formations on antiepileptic drug-induced liver injuries.
    Sasaki E; Yokoi T
    J Toxicol Sci; 2018; 43(2):75-87. PubMed ID: 29479037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cytochrome P450-mediated metabolism and identification of novel thiol-conjugated metabolites in mice with phenytoin-induced liver injury.
    Sasaki E; Iwamura A; Tsuneyama K; Fukami T; Nakajima M; Kume T; Yokoi T
    Toxicol Lett; 2015 Jan; 232(1):79-88. PubMed ID: 25455449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mouse model for phenytoin-induced liver injury: involvement of immune-related factors and P450-mediated metabolism.
    Sasaki E; Matsuo K; Iida A; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
    Toxicol Sci; 2013 Nov; 136(1):250-63. PubMed ID: 23986454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in gene expression induced by carbamazepine and phenytoin: testing the danger hypothesis.
    Lu W; Li X; Uetrecht JP
    J Immunotoxicol; 2008 Apr; 5(2):107-13. PubMed ID: 18569379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic toxicity of antiepileptic drugs: a review.
    Gram L; Bentsen KD
    Acta Neurol Scand Suppl; 1983; 97():81-90. PubMed ID: 6424399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment of animal models of drug-induced liver injury and analysis of possible mechanisms].
    Oda S; Yokoi T
    Yakugaku Zasshi; 2015; 135(4):579-88. PubMed ID: 25832838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury.
    Amacher DE
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):335-47. PubMed ID: 22288564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic basis for idiosyncratic reactions to antiepileptic drugs.
    Franciotta D; Kwan P; Perucca E
    Curr Opin Neurol; 2009 Apr; 22(2):144-9. PubMed ID: 19262378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamazepine-Induced Liver Injury Requires CYP3A-Mediated Metabolism and Glutathione Depletion in Rats.
    Iida A; Sasaki E; Yano A; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
    Drug Metab Dispos; 2015 Jul; 43(7):958-68. PubMed ID: 25870103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations.
    Teschke R
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs.
    Leeder JS
    Epilepsia; 1998; 39 Suppl 7():S8-16. PubMed ID: 9798756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Models of Idiosyncratic Drug-Induced Liver Injury.
    Yokoi T; Oda S
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():247-268. PubMed ID: 32976738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins.
    Usui T; Mise M; Hashizume T; Yabuki M; Komuro S
    Drug Metab Dispos; 2009 Dec; 37(12):2383-92. PubMed ID: 19720731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
    Utkarsh D; Loretz C; Li AP
    Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies.
    Teschke R; Danan G
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation and inflammation reactions involved in carbamazepine-induced liver injury.
    Higuchi S; Yano A; Takai S; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
    Toxicol Sci; 2012 Nov; 130(1):4-16. PubMed ID: 22790970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.
    Gómez-Lechón MJ; Tolosa L; Donato MT
    J Appl Toxicol; 2016 Jun; 36(6):752-68. PubMed ID: 26691983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of felbamate and other antiepileptic drug toxicity potential based on hepatic protein covalent binding and gene expression.
    Leone AM; Kao LM; McMillian MK; Nie AY; Parker JB; Kelley MF; Usuki E; Parkinson A; Lord PG; Johnson MD
    Chem Res Toxicol; 2007 Apr; 20(4):600-8. PubMed ID: 17381134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin metabolism by human cytochrome P450: involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formation.
    Cuttle L; Munns AJ; Hogg NA; Scott JR; Hooper WD; Dickinson RG; Gillam EM
    Drug Metab Dispos; 2000 Aug; 28(8):945-50. PubMed ID: 10901705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury.
    Tolosa L; Jiménez N; Pérez G; Castell JV; Gómez-Lechón MJ; Donato MT
    Arch Toxicol; 2018 Jan; 92(1):383-399. PubMed ID: 28762043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.